Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-025742

CEO sold 4,122 shares at $21.38 ($88,108)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-17 Sale : show line 1 in the form −4,122 $21.38 $88,108 521,642 D
Open-market sales · 4,122 sh · avg $21.38 · $88,108
Loading xslF345X04/form4.xml…